Home › Funds › One Capital Management, LLC › REGN

One Capital Management, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

One Capital Management, LLC reported holding 22,368 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$17.3M, representing 0.48% of its reported portfolio and ranking #47 among its reported holdings. One Capital Management, LLC has disclosed REGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)22.37K sh
Reported value held$17.28M
Portfolio Weight0.48%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How One Capital Management, LLC's REGN position evolved

One Capital Management, LLC first disclosed a stake in REGN in Q3 2023 at 11,335 shares (US$9.3M). The position peaked in Q1 2026 at 22,368 shares, worth US$17.3M. Across 12 filings, One Capital Management, LLC increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 22,368 shares valued at US$17.3M. Notable position changes include a 33% increase in Q2 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.34K $9.33M New
Q4 2023 10.97K $9.63M Reduce
Q1 2024 10.99K $10.58M Hold
Q2 2024 11.67K $12.26M Add
Q3 2024 12.18K $12.80M Add
Q4 2024 12.49K $8.89M Add
Q1 2025 14.82K $9.40M Add
Q2 2025 19.72K $10.35M Add
Q3 2025 20.86K $11.73M Add
Q4 2025 21.62K $16.69M Add
Q1 2026 22.37K $17.28M Add
Q2 2026 22.37K $17.28M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has One Capital Management, LLC held REGN?

One Capital Management, LLC has disclosed REGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is One Capital Management, LLC's current position in REGN?

As of Q2 2026, One Capital Management, LLC holds 22.37K shares of REGN (REGENERON PHARMACEUTICALS), valued at $17.28M, representing 0.48% of its reported portfolio and ranking #47.

Has One Capital Management, LLC been buying or selling REGN?

In the latest 13F filing (Q2 2026), One Capital Management, LLC held unchanged its position in REGN. The position peaked in Q1 2026 at 22.37K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.